These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26111021)

  • 21. Refractory generalised convulsive status epilepticus : a guide to treatment.
    Kälviäinen R; Eriksson K; Parviainen I
    CNS Drugs; 2005; 19(9):759-68. PubMed ID: 16142991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraoperative refractory status epilepticus caused by propofol -a case report.
    Kumar A; Kumar A; Kumar N; Kumar A
    Korean J Anesthesiol; 2021 Feb; 74(1):70-72. PubMed ID: 32388939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Not Available].
    Flügel D
    Praxis (Bern 1994); 2017 Feb; 106(3):143-150. PubMed ID: 28169598
    [No Abstract]   [Full Text] [Related]  

  • 24. Commentary on ‘propofol versus thiopental sodium for the treatment of refractory status epilepticus—still no answer’.
    Buchhalter J; Stang A
    Evid Based Child Health; 2013 Jul; 8(4):1509-10. PubMed ID: 24040681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiepileptic drugs for seizure control in people with neurocysticercosis.
    Sharma M; Singh T; Mathew A
    Cochrane Database Syst Rev; 2015 Oct; (10):CD009027. PubMed ID: 26455722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of ketamine in refractory status epilepticus in children.
    Rosati A; L'Erario M; Ilvento L; Cecchi C; Pisano T; Mirabile L; Guerrini R
    Neurology; 2012 Dec; 79(24):2355-8. PubMed ID: 23197747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Felbamate as an add-on therapy for refractory epilepsy.
    Shi LL; Dong J; Ni H; Geng J; Wu T
    Cochrane Database Syst Rev; 2014 Jul; (7):CD008295. PubMed ID: 25036694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Felbamate as an add-on therapy for refractory partial epilepsy.
    Shi LL; Dong J; Ni H; Geng J; Wu T
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD008295. PubMed ID: 28718506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of timing of continuous intravenous anesthetic drug treatment on outcome in refractory status epilepticus.
    Madžar D; Reindl C; Giede-Jeppe A; Bobinger T; Sprügel MI; Knappe RU; Hamer HM; Huttner HB
    Crit Care; 2018 Nov; 22(1):317. PubMed ID: 30463604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Propofol and midazolam in the treatment of refractory status epilepticus.
    Prasad A; Worrall BB; Bertram EH; Bleck TP
    Epilepsia; 2001 Mar; 42(3):380-6. PubMed ID: 11442156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiepileptic drugs for the treatment of infants with severe myoclonic epilepsy.
    Brigo F; Igwe SC
    Cochrane Database Syst Rev; 2015 Oct; (10):CD010483. PubMed ID: 26482210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preliminary results of the global audit of treatment of refractory status epilepticus.
    Ferlisi M; Hocker S; Grade M; Trinka E; Shorvon S;
    Epilepsy Behav; 2015 Aug; 49():318-24. PubMed ID: 25952268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melatonin as add-on treatment for epilepsy.
    Brigo F; Igwe SC
    Cochrane Database Syst Rev; 2016 Mar; 3():CD006967. PubMed ID: 26986179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. (S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study.
    Höfler J; Rohracher A; Kalss G; Zimmermann G; Dobesberger J; Pilz G; Leitinger M; Kuchukhidze G; Butz K; Taylor A; Novak H; Trinka E
    CNS Drugs; 2016 Sep; 30(9):869-76. PubMed ID: 27465262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ketamine reduces seizure and interictal continuum activity in refractory status epilepticus: a multicenter in-person and teleneurocritical care study.
    Harnicher B; Murray NM; Dresbach J; Collingridge DS; Reachi B; Bair J; Hoang Q; Fontaine GV
    Neurol Sci; 2024 Nov; 45(11):5449-5456. PubMed ID: 38862653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of lacosamide in children and adolescents with drug-resistant epilepsy and refractory status epilepticus: A systematic review.
    Ortiz de la Rosa JS; Ladino LD; Rodríguez PJ; Rueda MC; Polanía JP; Castañeda AC
    Seizure; 2018 Mar; 56():34-40. PubMed ID: 29428899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy.
    Powell G; Saunders M; Marson AG
    Cochrane Database Syst Rev; 2014 Feb; (2):CD007124. PubMed ID: 24488654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of propofol in refractory status epilepticus.
    Brown LA; Levin GM
    Ann Pharmacother; 1998 Oct; 32(10):1053-9. PubMed ID: 9793598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Losigamone add-on therapy for partial epilepsy.
    Xiao Y; Luo M; Wang J; Luo H
    Cochrane Database Syst Rev; 2015 Dec; (12):CD009324. PubMed ID: 26661741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy.
    Powell G; Saunders M; Rigby A; Marson AG
    Cochrane Database Syst Rev; 2014 Dec; (12):CD007124. PubMed ID: 25470302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.